Healthy Volunteer Receives NIAID Zika Virus Investigational DNA Vaccine (image) NIH/National Institute of Allergy and Infectious Diseases Share Print E-Mail Caption A healthy volunteer receives the NIAID Zika virus investigational DNA vaccine as part of an early-stage trial to test the vaccine's safety and immunogenicity. This is the first administration of this vaccine in a human. Credit NIAID Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.